NIK Controls Classical and Alternative NF-κB Activation and Is Necessary for the Survival of Human T-cell Lymphoma Cells

Lina Odqvist, Margarita Sánchez‐Beato, Santiago Montes‐Moreno, Esperanza Martín‐Sánchez, Raquel Pajares, Lydia Sánchez-Verde, Pablo L. Ortiz‐Romero, José Rodríguez, Socorro Marıá Rodríguez-Pinilla, F. Martínez,

Clinical Cancer Research · 2013 · 56 citations · 38 references

Abstract

The results of the present study indicate that NIK could be a promising therapeutic target in these aggressive malignancies.

References

38